Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12605000151639
Ethics application status
Approved
Date submitted
12/08/2005
Date registered
15/08/2005
Date last updated
15/08/2005
Type of registration
Retrospectively registered

Titles & IDs
Public title
Passive joint mobilisation for the treatment of shoulder pain
Scientific title
An evaluation of the effectiveness of passive mobilisation of shoulder joints for the treatment of shoulder pain: a randomised controlled clinical trial
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Rotator cuff syndrome
 242 0
Impingement syndrome 243 0
Painful arc syndrome 244 0
Condition category
Condition code
Alternative and Complementary Medicine 274 274 0 0
Pain management
Musculoskeletal 275 275 0 0

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Experimental intervention: advice, exercises and passive joint mobilisations at shoulder region joints
Intervention code [1] 181 0
Treatment: Other
Comparator / control treatment
Control intervention: advice and exercises
Control group
Active

Outcomes
Primary outcome [1] 323 0
* Shoulder Pain and Disability Index questionnaire (SPADI)
Timepoint [1] 323 0
At 1, 3 and 6 months after randomisation
Primary outcome [2] 324 0
* Self-assessed improvement measured on a Likert scale consisting of the following 6 categories: much worse, slightly worse, same, slightly improved, greatly improved, and fully recovered
Timepoint [2] 324 0
At 1, 3 and 6 months after randomisation
Secondary outcome [1] 723 0
Painful active abduction and flexion range of motion.
Timepoint [1] 723 0
At 1, 3 and 6 months after randomisation.

Eligibility
Key inclusion criteria
Subjects will be included if they have pain over the glenohumeral joint or in the proximal upper limb during shoulder movements and maintenance of at least 75% of normal active abduction and flexion range of movement.
Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Subjects will be excluded from the study if: shoulder symptoms are exacerbated during active cervical movements with and/or without overpressure and/or during cervical or thoracic region palpation; they are complaining of parathesia in the affected upper limb; passive shoulder joint mobilisation is contra-indicated; shoulder forward flexion and/or abduction is less than 75% active range of movement; shoulder pain is due to an inflammatory or neoplastic disorder; they have had surgery or trauma to the shoulder in the previous 4 weeks; or they are experiencing a feeling of shoulder instability.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
numbered envelopes - concealed allocation
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
random numbers generated using the "rand()" function in Microsoft Excel
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
blinded assessmenrt used
Phase
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
1/05/2005
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
40
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 329 0
Self funded/Unfunded
Name [1] 329 0
Country [1] 329 0
Primary sponsor type
Individual
Name
Dr Karen Ginn
Address
Country
Secondary sponsor category [1] 262 0
Individual
Name [1] 262 0
Dr Meg Stuart
Address [1] 262 0
Country [1] 262 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 1264 0
Royal Prince Alfred Hospital Sydney University of Sydney
Ethics committee address [1] 1264 0
Ethics committee country [1] 1264 0
Australia
Date submitted for ethics approval [1] 1264 0
Approval date [1] 1264 0
Ethics approval number [1] 1264 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 36020 0
Address 36020 0
Country 36020 0
Phone 36020 0
Fax 36020 0
Email 36020 0
Contact person for public queries
Name 9370 0
Dr Karen Ginn
Address 9370 0
University of Sydney
Cumberland Campus
PO Box 170
Lidcombe NSW 1825
Country 9370 0
Australia
Phone 9370 0
+61 2 93519352
Fax 9370 0
Email 9370 0
K.Ginn@fhs.usyd.edu.au
Contact person for scientific queries
Name 298 0
Dr Karen Ginn
Address 298 0
University of Sydney
Cumberland Campus
PO Box 170
Lidcombe NSW 1825
Country 298 0
Australia
Phone 298 0
+61 2 93519352
Fax 298 0
Email 298 0
K.Ginn@fhs.usyd.edu.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
TypeIs Peer Reviewed?DOICitations or Other DetailsAttachment
Basic resultsNo 189-(Uploaded-14-11-2019-12-17-25)-Basic results summary.docx

Documents added automatically
No additional documents have been identified.